196 related articles for article (PubMed ID: 29497099)
1. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.
Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK
Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099
[TBL] [Abstract][Full Text] [Related]
2. MED12 exon 2 and TERT promoter mutations in primary and recurrent breast fibroepithelial lesions.
Hu Y; Li G; Wang L; Zhang L; Guan J; Wang J
Pathol Int; 2021 Dec; 71(12):814-822. PubMed ID: 34597441
[TBL] [Abstract][Full Text] [Related]
3. Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Piscuoglio S; Ng CK; Murray M; Burke KA; Edelweiss M; Geyer FC; Macedo GS; Inagaki A; Papanastasiou AD; Martelotto LG; Marchio C; Lim RS; Ioris RA; Nahar PK; Bruijn ID; Smyth L; Akram M; Ross D; Petrini JH; Norton L; Solit DB; Baselga J; Brogi E; Ladanyi M; Weigelt B; Reis-Filho JS
J Pathol; 2016 Mar; 238(4):508-18. PubMed ID: 26832993
[TBL] [Abstract][Full Text] [Related]
4. MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
Garcia-Dios DA; Levi D; Shah V; Gillett C; Simpson MA; Hanby A; Tomlinson I; Sawyer EJ
Br J Cancer; 2018 Jan; 118(2):277-284. PubMed ID: 29315289
[TBL] [Abstract][Full Text] [Related]
5. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast.
Yoshida M; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Hiraoka N; Sekine S
Br J Cancer; 2015 Oct; 113(8):1244-8. PubMed ID: 26355235
[TBL] [Abstract][Full Text] [Related]
6. [Pathological features and clinicopathological significance of TERT promoter mutation in breast fibroepithelial tumors without definite diagnosis].
Wang JG; Hu YJ; Guan JJ; Liu HY; Bi ZJ; Zhang LX; Liu YX; Xing XM
Zhonghua Bing Li Xue Za Zhi; 2023 Feb; 52(2):153-159. PubMed ID: 36748136
[No Abstract] [Full Text] [Related]
7. Analysis of phyllodes tumor recurrence according to the histologic grade.
Kim S; Kim JY; Kim DH; Jung WH; Koo JS
Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
[TBL] [Abstract][Full Text] [Related]
8. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.
Yoon N; Bae GE; Kang SY; Choi MS; Hwang HW; Kim SW; Lee JE; Nam SJ; Gong G; Lee HJ; Bae YK; Lee A; Cho EY
Genes Chromosomes Cancer; 2016 Jun; 55(6):495-504. PubMed ID: 26856273
[TBL] [Abstract][Full Text] [Related]
9. Periductal Stromal Tumor of the Breast with a
Anderson B; Marotti JD; Lefferts JA; Muller KE
Int J Surg Pathol; 2023 Dec; 31(8):1626-1631. PubMed ID: 36823780
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
11. Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.
Otsuji K; Sasaki T; Tanabe M; Seto Y
Br J Cancer; 2021 Jan; 124(2):466-473. PubMed ID: 33046803
[TBL] [Abstract][Full Text] [Related]
12. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
[TBL] [Abstract][Full Text] [Related]
13. Association Between Recurrence and Re-Excision for Close and Positive Margins Versus Observation in Patients with Benign Phyllodes Tumors.
Moo TA; Alabdulkareem H; Tam A; Fontanet C; Lu Y; Landers A; D'Alfonso T; Simmons R
Ann Surg Oncol; 2017 Oct; 24(10):3088-3092. PubMed ID: 28766221
[TBL] [Abstract][Full Text] [Related]
14. Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors.
Kim GE; Kim JH; Lee KH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Park MH; Yoon JH
Appl Immunohistochem Mol Morphol; 2012 May; 20(3):298-303. PubMed ID: 22505012
[TBL] [Abstract][Full Text] [Related]
15. Risk of Local Recurrence of Benign and Borderline Phyllodes Tumors: A Danish Population-Based Retrospective Study.
Borhani-Khomani K; Talman ML; Kroman N; Tvedskov TF
Ann Surg Oncol; 2016 May; 23(5):1543-8. PubMed ID: 26714948
[TBL] [Abstract][Full Text] [Related]
16. Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.
Adam MJ; Bendifallah S; Kalhorpour N; Cohen-Steiner C; Ropars L; Mahmood A; Rousseau C; Leveque J; Nyangoh Timoh K; Der Some A; Ouldamer L; Legendre G; Ballester M; Daraï E; Canlorbe G; Lavoue V
Eur J Surg Oncol; 2018 Nov; 44(11):1743-1749. PubMed ID: 30195948
[TBL] [Abstract][Full Text] [Related]
17. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
[TBL] [Abstract][Full Text] [Related]
18. Benign and low-grade fibroepithelial neoplasms of the breast have low recurrence rate after positive surgical margins.
Cowan ML; Argani P; Cimino-Mathews A
Mod Pathol; 2016 Mar; 29(3):259-65. PubMed ID: 26743469
[TBL] [Abstract][Full Text] [Related]
19. Recurrent
Pareja F; Da Cruz Paula A; Murray MP; Hoang T; Gularte-Mérida R; Brown D; da Silva EM; Sebastiao APM; Giri DD; Weigelt B; Reis-Filho JS; Brogi E
J Clin Pathol; 2019 Mar; 72(3):258-262. PubMed ID: 30467240
[TBL] [Abstract][Full Text] [Related]
20. In phyllodes tumour of the breast expression of c-kit but not of ALDH1A1 is associated with adverse clinico-pathological features.
Chougule A; Bal A; Das A; Kohli PS; Singh G
Virchows Arch; 2016 Dec; 469(6):651-658. PubMed ID: 27696244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]